10.26.04: C.E. Unterberg, Towbin Specialty Pharmaceutical Conference Issue
An analyst and top management from 10 firms examine the Pharmaceutical sector in this 51 page conference issue from The Wall Street Transcript.

  1. Outlook for Specialty Pharmaceuticals: Angela Larson, Managing Director, Equity Research Team

  2. CEO Interviews (average 2,500 words): Top management from 10 sector firms examine the outlook for their firm and the sector. Firms interviewed include: AVANIR Pharmaceuticals, Auxilium Pharmaceuticals, Barrier Therapeutics, CollaGenex Pharmaceuticals, Depomed, DURECT Corporation, Enzon Pharmaceuticals, ISTA Pharmaceuticals, Nabi Biopharmaceuticals and SkinMedica.

    Topics covered: Product development  - Generics sector  - Regulatory approval standards  - Investor interest  - Specialty pharma  - Offsetting production costs  - Role of R&D  - Using safety data  - Growth rate expectations  - Valuations 
    Companies covered: Connetics Corp. (CNCT), Endo Pharmaceuticals (ENDP), Salix Pharmaceuticals (SLXP).
    ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us

    For immediate access online - click here to gain a password.  

    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
           		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE